Source:http://linkedlifedata.com/resource/pubmed/id/20949403
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2010-10-15
|
| pubmed:abstractText |
Tissue microarray (TMA) technology is a robust "high throughput" method of tissue analysis, whereby a large number of patient samples can be examined in a short time using a minimum number of slides. In a TMA, cylinders of tissue are cored out of formalin-fixed, paraffin-embedded tissue blocks and slotted in a regular grid pattern into a blank recipient paraffin wax block. The TMA block is then cut using a standard laboratory microtome. Sections generated are suitable for all in situ techniques, such as immunohistochemistry (IHC) and in situ hybridisation, using essentially the same protocols as are used in conventional sections. The principle advantages of TMAs are that they save valuable biological material and ensure more reproducible reaction conditions while at the same time reducing re-agent costs and laboratory processing. Immunohistochemical studies designed to examine the prognostic utility of TMAs compared with large sections have generally found that they are comparable.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1940-6029
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
675
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
363-73
|
| pubmed:meshHeading | |
| pubmed:year |
2011
|
| pubmed:articleTitle |
A practical guide to constructing and using tissue microarrays.
|
| pubmed:affiliation |
Royal Cancer Hospital Cancer Genetics, Sutton, Surrey, London, UK.
|
| pubmed:publicationType |
Journal Article
|